Addus HomeCare Co. (NASDAQ:ADUS) Receives Consensus Rating of “Buy” from Brokerages

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have received a consensus rating of “Buy” from the ten ratings firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have given a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $132.78.

A number of research analysts have issued reports on the company. Stephens restated an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. JMP Securities assumed coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective for the company. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Macquarie restated an “outperform” rating and issued a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. Finally, StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 4.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Quarry LP bought a new stake in shares of Addus HomeCare during the 3rd quarter valued at about $28,000. Natixis lifted its position in Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after purchasing an additional 132 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after purchasing an additional 214 shares during the last quarter. Parkside Financial Bank & Trust lifted its position in Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after purchasing an additional 148 shares during the last quarter. Finally, Meeder Asset Management Inc. purchased a new position in shares of Addus HomeCare during the fourth quarter valued at approximately $77,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Trading Down 0.6 %

NASDAQ ADUS opened at $90.28 on Monday. The firm has a market capitalization of $1.64 billion, a P/E ratio of 20.66, a PEG ratio of 1.41 and a beta of 0.97. The business has a fifty day simple moving average of $115.30 and a 200 day simple moving average of $123.17. Addus HomeCare has a 12 month low of $87.88 and a 12 month high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million during the quarter, compared to analysts’ expectations of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, sell-side analysts predict that Addus HomeCare will post 4.59 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.